| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 02/17/2005 | WO2005015154A2 Autocatalysis/yeast two-hybrid assay |
| 02/17/2005 | WO2005014848A2 IMPROVED ELECTROPHYSIOLOGICAL ASSAYS USING OOCYTES THAT EXPRESS HUMAN ENaC AND THE USE OF PHENAMIL TO IMPROVE THE EFFECT OF ENaC ENHANCERS IN ASSAYS USING MEMBRANE POTENTIAL REPORTING DYES |
| 02/17/2005 | WO2005014812A2 An antisense oligonucleotide to inhibit melanoma inhibitory activity, mia |
| 02/17/2005 | WO2005014796A2 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/17/2005 | WO2005014790A2 Polypeptides having oxaloecetate hydrolase activity and polynucleotides encoding same |
| 02/17/2005 | WO2005014788A2 Tssk4: a human testis specific serine/threonine kinase |
| 02/17/2005 | WO2005014779A2 Cyclodextrin affinity purification |
| 02/17/2005 | WO2005014646A1 Method for producing a polypeptide |
| 02/17/2005 | WO2005014612A1 Novel splice variant of ctla-4 |
| 02/17/2005 | WO2005014609A2 Method of producing a highly stereoregular phosphorus atom-modified nucleotide analogue |
| 02/17/2005 | WO2005013901A2 Oligomeric compounds and compositions for use in modulation of small non-coding rnas |
| 02/17/2005 | WO2004099131A3 Compounds having a fused, bicyclic moiety for binding to the minor groove of dsdna |
| 02/17/2005 | WO2004092396A3 Flap endonuclease 1 (fen1) regulatory sequences and uses thereof |
| 02/17/2005 | WO2004087730A8 Method for producing diverse libraries of encoded polymers |
| 02/17/2005 | WO2004051218A3 Multiplex amplification of polynucleotides |
| 02/17/2005 | WO2004047740A3 Composition and method for treating lupus nephritis |
| 02/17/2005 | WO2004033471A3 Glucose transport mutants for production of biomaterial |
| 02/17/2005 | WO2004031402A3 Methylation profile of cancer |
| 02/17/2005 | WO2004016805A3 Immunostimulatory nucleic acids |
| 02/17/2005 | WO2004014312A3 Small-mer compositions and methods of use |
| 02/17/2005 | WO2004000872A3 Improved alphavirus vectors having attenuated virion structural proteins |
| 02/17/2005 | WO2003102214A3 Method for efficient rna interference in mammalian cells |
| 02/17/2005 | WO2003070910A3 INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 02/17/2005 | US20050039234 Expression vector comprising nucleotide sequences coding desaturase for use in increasing/decreasing palmitoleic acid and/or vaccenic acid concentrations in seed |
| 02/17/2005 | US20050039226 Expression vector comprising nucleotide sequences for conferring insect resistance to a plant; transgenic insect resistant maize |
| 02/17/2005 | US20050039220 Labeled coronavirus protein for use as diagnostic tool in detection of viral infection; viricides and vaccine development for treatment and prevention of respiratory system disorders |
| 02/17/2005 | US20050038234 Bi-functionalised metallocenes use for marking biological molecules |
| 02/17/2005 | US20050037988 Determination competitive binder between Rna and target compound in plants |
| 02/17/2005 | US20050037985 Administering CpG oligonucleotide to patient infected with human immunodeficiency virus |
| 02/17/2005 | US20050037957 Polypeptide as target of drugs to detect central nervous system disorders, cancer, metabolism and cardiovascular disorders |
| 02/17/2005 | US20050037459 Variant humicola grisea CBH1.1 |
| 02/17/2005 | US20050037458 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/17/2005 | US20050037456 Purification of polypeptides |
| 02/17/2005 | US20050037454 Expression vector comprising nuclelotide sequences coding osteoblast protein for use in diagnosis, prevention and treatment of osteoporosis and bone resorption disorders |
| 02/17/2005 | US20050037439 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 02/17/2005 | US20050037432 Macroglobulin peptides for use as diagnostic indicator of osteoarthritis, bone and tissue disorders |
| 02/17/2005 | US20050037425 mmFP encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 02/17/2005 | US20050037416 Hybrid nucleic acid; isolation antibody |
| 02/17/2005 | US20050037412 Thermostable Taq polymerase fragment |
| 02/17/2005 | US20050037411 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use |
| 02/17/2005 | US20050037403 Immunomodulatory oligonucleotides |
| 02/17/2005 | US20050037399 nucleic acid having a specific nucleotide sequence, used to diagnose or determine predisposition to adenocarcinoma. |
| 02/17/2005 | US20050037397 Bio-barcode based detection of target analytes |
| 02/17/2005 | US20050037396 compounds for analyzing primer extension products incorporating universal bases; microsatellite analysis |
| 02/17/2005 | US20050037391 Polypeptide |
| 02/17/2005 | US20050037387 Modulation of the RNA interference pathway |
| 02/17/2005 | US20050037383 Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof |
| 02/17/2005 | US20050037379 Reagents and methods useful for detecting diseases of the prostate |
| 02/17/2005 | US20050037362 Using microarray hybridization to quantify and analyze RNA interference; detection, identification and/or quantification of multiple gene-specific short interfering RNA sequences |
| 02/17/2005 | US20050037346 Distinguish minority template in the presence of an excess of normal template with a thermostable ligase; useful for the detection of cancer-associated mutations; quantitative measure of the amount or ratio of minority template; a thermostable mutant ligase |
| 02/17/2005 | US20050037340 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 02/17/2005 | US20050037026 such as Alzheimer's disease; amyloid precursor proteins; comprises diphtheria toxoid as carrier |
| 02/17/2005 | US20050036997 Molecular modeling of the binding sites for anisomycin, azithromycin, erythromycin, linezolid, tylosin, carbomycin A, spiramycin, virginiamycin, sparsomycin and blasticidin using the Haloarcular marismortui large ribosomal subunit; drug design and drug screening |
| 02/17/2005 | US20050036995 Immunogens; tumor antigens; kits |
| 02/17/2005 | DE10333508A1 New recognition molecules for the prothrombin gene, useful for treatment, diagnosis and monitoring of thromboembolic disease, target a specific region in prothrombin mRNA |
| 02/17/2005 | CA2534971A1 5'-and 3'-capped aptamers and uses therefor |
| 02/17/2005 | CA2534658A1 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | CA2534365A1 Diagnostic and therapeutics for osteoporosis |
| 02/17/2005 | CA2530497A1 Improved electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
| 02/17/2005 | CA2528569A1 Method for producing a polypeptide |
| 02/17/2005 | CA2524767A1 Cyclodextrin affinity purification |
| 02/16/2005 | EP1507005A2 Antisense modulation of BCL-X expression |
| 02/16/2005 | EP1507002A2 Thermostable Taq polymerase fragment |
| 02/16/2005 | EP1506959A2 Derivatised molecules for mass spectrometry |
| 02/16/2005 | EP1506328A2 Fabrication of a high resolution biological molecule detection device with gold electrical conductors |
| 02/16/2005 | EP1506295A2 Muteins of placental growth factor type 1, preparation method and application thereof |
| 02/16/2005 | EP1506286A2 Neutralizing human anti-igfr antibody |
| 02/16/2005 | EP0958376B1 Prolactin receptor gene as a genetic marker for increased litter size in pigs |
| 02/16/2005 | EP0957926B1 Oligonucleotide compositions and methods for the modulation of the expression of b7 protein |
| 02/16/2005 | EP0634896B1 Evaluation of patients with progressive immunosuppression |
| 02/16/2005 | CN1582336A Moraxella (branhamella) catarrhalis antigens |
| 02/16/2005 | CN1582297A Hybrid and tandem expression of neisserial proteins |
| 02/16/2005 | CN1582156A Methods for treating ocular neovascular diseases |
| 02/16/2005 | CN1580274A Mongolian radix astragali isoflavone synthetase gene and its full-length cDNA sequence |
| 02/16/2005 | CN1580266A Method for extablishing polymorphism adenoid tumour mouse model |
| 02/16/2005 | CN1580259A SiRAN and expression carrier for inhibiting human VEGF gene expression and their pharmaceutical use |
| 02/16/2005 | CN1580258A SiRNA and expression plasmid for inhibiting human bc1-2 gene expression and their use for preparing medicine |
| 02/16/2005 | CN1580252A Artificial endo enzyme containing peptide nucleic acid recognition element, and its preparing method and use |
| 02/16/2005 | CN1580250A Method for establishing mouse full-genome mutoation ES cell bank |
| 02/16/2005 | CN1580249A Method for screening and establishing mouse-development-related gene mutation ES cell bank |
| 02/16/2005 | CN1580072A SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use |
| 02/16/2005 | CN1580070A Anti HBV infection and hepatitis B-preventing nucleotide sequence and its use |
| 02/16/2005 | CN1580069A Interleukin-2 and enterotoxin B fusion gene and its preparation |
| 02/16/2005 | CN1580068A Method for preparing injection ribonucleic acid of human placenta |
| 02/16/2005 | CN1580067A Magnetic nano particle nucleic acid separator, and its preparing method and use |
| 02/16/2005 | CN1189563C Cloning-free linear expression vector constituting method |
| 02/16/2005 | CN1189556C Improved riboflavin prodn. |
| 02/16/2005 | CN1189482C Novel angiogenesis inhibitor |
| 02/16/2005 | CN1189474C Method of separating whole length, complete messnger RNA from total RNA |
| 02/15/2005 | US6855817 Materials and methods for binding nucleic acids to surfaces |
| 02/15/2005 | US6855816 Method for producing endotoxin-free nucleic acids and the use thereof |
| 02/15/2005 | US6855815 Introducing a nucleic acid to a host cell, growing host cell to express nucleic acid as a transcript and such transcript is expressed as a translation product containing cellular inhibitor of apoptosis protein |
| 02/15/2005 | US6855522 Polymerase chain reaction; medical diagnosis of skin disorders |
| 02/15/2005 | US6855501 Transfer of arrayed chemical compositions |
| 02/15/2005 | US6855500 Fluorescence-based genotyping |
| 02/15/2005 | US6855496 Detection of preferential nucleic acid ligands; obtain nucleotide sequences, incubate with oligonucleotides, hybridize, amplify, recover nucleotide sequences |
| 02/15/2005 | US6855319 Gene encoding merozoite protein of Babesia caballi, recombinant protein obtained therefrom and utilization thereof |
| 02/10/2005 | WO2005012579A2 Homodimeric cyanine dye dimer comprising aromatic, heteroaromatic, cyclic or heterocyclic linker moiety in nucleic acid reporter molecules |
| 02/10/2005 | WO2005012547A2 Multimeric oxidoreductases |
| 02/10/2005 | WO2005012531A2 Antibody cdr polypeptide sequences with restricted diversity |